hormone receptor positive

Questions discussed in this category

In what clinical scenarios, if any, would you consider using sacituzumab govitecan prior to trastuzumab deruxtecan for HR+/HER2- metastatic breast cancer treatment?

ASCENT-07 data recently did not meet the endpoint for progression-free survival for sacituzumab govitecan as a first-line treatment post-endocrine the...

1 Answer available

hormone receptor positive

Questions discussed in this category

Related Topics